Chemical Structure : PRN1008
CAS No.: 1575596-29-0
货号: PC-62583Not For Human Use, Lab Use Only.
Rilzabrutinib (PRN1008) is a potent, selective, covalent reversible BTK inhibitorwith IC50 of 1.3 nM.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥1580 | In stock | |
10 mg | ¥2480 | In stock | |
25 mg | ¥4280 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Rilzabrutinib (PRN1008) is a potent, selective, covalent reversible BTK inhibitorwith IC50 of 1.3 nM.
PRN1008 displays highly selectively when tested in a panel of 251 other kinases.
PRN1008 inhibits anti-IgM induces human B cell proliferation (10% serum) and B cell CD69 expression, with IC50s of 5 nM and 123 nM, respectively.
Rilzabrutinib (PRN1008) demonstrates in vivo efficacy in rodent arthritis models, and clinical efficacy in canine pemphigus foliaceus.
Rilzabrutinib (PRN1008) is in phase 3 trials for pemphigus vulgaris and immune thrombocytopenia.
分子量 | 665.774 | |
分子式 | C36H40FN9O3 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
(R,E)-2-(3-(4-amino-3-(2-fluoro-4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carbonyl)-4-methyl-4-(4-(oxetan-3-yl)piperazin-1-yl)pent-2-enenitrile |
1. Smith PF, et al. Br J Clin Pharmacol. 2017 Nov;83(11):2367-2376.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright